JPMorgan Chase & Co. set a €72.00 ($84.71) price objective on Gerresheimer (ETR:GXI) in a report published on Wednesday. The firm currently has a neutral rating on the stock.
A number of other research firms have also issued reports on GXI. Kepler Capital Markets set a €65.00 ($76.47) price target on shares of Gerresheimer and gave the company a sell rating in a report on Thursday, July 12th. Goldman Sachs Group set a €70.00 ($82.35) price target on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, July 12th. Commerzbank set a €68.00 ($80.00) price target on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, July 12th. equinet set a €69.00 ($81.18) price target on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, July 12th. Finally, Hauck & Aufhaeuser set a €52.50 ($61.76) price target on shares of Gerresheimer and gave the company a sell rating in a report on Monday, July 16th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. Gerresheimer presently has an average rating of Hold and an average price target of €70.13 ($82.50).
Get Gerresheimer alerts:GXI stock opened at €74.05 ($87.12) on Wednesday. Gerresheimer has a 52-week low of €59.97 ($70.55) and a 52-week high of €78.25 ($92.06).
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Recommended Story: Book Value Of Equity Per Share �� BVPS Explained
No comments:
Post a Comment